0
 

Biosimilars Market - Company Profile (Novartis (Sandoz), Synthon Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., LG Life Sciences, Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec, Inc., and Genentech (Roche Group).)and Competitive intelligence report 2017

  • ID: CP_LI_188719
  • September 2015
  • 48 pages
  • Price: $ 595
 
 

The key companies profiled in this report are Novartis (Sandoz), Synthon Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., LG Life Sciences, Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec, Inc., and Genentech (Roche Group).

 

TOC

Chapter: 1 COMPANY PROFILES

1.1 Novartis (Sandoz)

1.1.1 Company overview

1.1.2 Company snapshot

1.1.3 Operating business segment overview

1.1.4 Business performance

1.1.5 Key strategies

1.1.5.1 Primary Strategies: Clinical Trials

1.1.5.2 secondary Strategies: approval

1.1.6 SWOT analysis

1.2 Synthon Pharmaceuticals, Inc.

1.2.1 Company overview

1.2.2 Company snapshot

1.2.3 Operating business segment overview

1.2.4 Key strategies

1.2.4.1 Primary Strategies: agreement

1.2.4.2 secondary Strategies: clinical trials

1.2.5 SWOT analysis

1.3 Teva Pharmaceutical Industries Ltd.

1.3.1 Company Overview

1.3.2 Company Snapshot

1.3.3 Operating business segment overview

1.3.4 Business performance

1.3.5 Key strategies

1.3.5.1 Primary Strategies: approval

1.3.5.2 secondary Strategies: clinical trials

1.3.6 SWOT analysis

1.4 LG Life Sciences

1.4.1 Company overview

1.4.2 Company snapshot

1.4.3 Operating business segment overview

1.4.4 Business performance

1.4.5 Key strategies

1.4.5.1 Primary Strategies: Collaboration

1.4.6 SWOT analysis

1.5 Celltrion

1.5.1 Company overview

1.5.2 Company snapshot

1.5.3 Operating business segment overview

1.5.4 Business Performance

1.5.5 Key strategies

1.5.5.1 Primary Strategies: approval

1.5.6 SWOT analysis

1.6 Biocon

1.6.1 Company overview

1.6.2 Company snapshot

1.6.3 Operating business segment overview

1.6.4 Business Performance

1.6.5 Key strategies

1.6.5.1 Primary Strategy: product launch

1.6.5.2 secondary Strategy: clinical trial

1.6.6 SWOT analysis

1.7 Hospira

1.7.1 Company overview

1.7.2 Company snapshot

1.7.3 Operating business segment overview

1.7.4 Business performance

1.7.5 Key strategies

1.7.5.1 Primary Strategies: approval

1.7.5.2 secondary Strategies: clinical trials

1.7.6 SWOT analysis

1.8 Merck Serono (Merck Group)

1.8.1 Company overview

1.8.2 Company snapshot

1.8.3 Operating business segment overview

1.8.4 Business performance

1.8.5 Key strategies

1.8.5.1 Primary Strategies: partnership and product launch

1.8.6 SWOT analysis

1.9 Biogen idec Inc.

1.9.1 Company overview

1.9.2 Company snapshot

1.9.3 Operating business segment overview

1.9.4 Business performance

1.9.5 Key strategies

1.9.5.1 Primary Strategies: agreement and joint venture

1.9.6 SWOT analysis

1.10 Genentech (Roche Group)

1.10.1 Company overview

1.10.2 Company snapshot

1.10.3 Operating business segment overview

1.10.4 Key strategies

1.10.4.1 Primary Strategies: Investment and license

1.10.5 SWOT analysis

 

LIST OF TABLES AND FIGURES

-

Purchase Options

 

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers